These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 85602)

  • 1. The spinal cord protein (SCP): appraisal of physiological and immunological hypotheses of anti-encephalitogenic action.
    MacPherson CF
    Immunochemistry; 1978 Nov; 15(10-11):767-75. PubMed ID: 85602
    [No Abstract]   [Full Text] [Related]  

  • 2. Partial characterization of the human anti-encephalitogenic protein: isolation from spinal cord and spinal nerves.
    Weir KG; MacPherson CF
    Biochim Biophys Acta; 1978 Feb; 532(2):232-41. PubMed ID: 75025
    [No Abstract]   [Full Text] [Related]  

  • 3. One-way cross-reaction between spinal cord protein and myelin basic protein.
    MacPherson CF; Prokopchuk P; Ramshaw IA; Ziola B
    Prog Clin Biol Res; 1984; 146():265-70. PubMed ID: 6201898
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunochemical and biochemical studies demonstrating the identity of a bovine spinal cord protein (SCP) and a basic protein of bovine peripheral myelin (BF).
    Deibler GE; Driscoll BF; Kies MW
    J Neurochem; 1978 Feb; 30(2):401-12. PubMed ID: 415121
    [No Abstract]   [Full Text] [Related]  

  • 5. Prevention of experimental allergic encephalitis in Lewis rats by rat and bovine spinal cord proteins.
    MacPherson CF; Armstrong H
    Nature; 1977 Mar; 266(5601):459-61. PubMed ID: 67565
    [No Abstract]   [Full Text] [Related]  

  • 6. Immuno-electron microscopic localization of the encephalitogenic basic protein in myelin.
    Herndon RM; Rauch HC; Einstein ER
    Immunol Commun; 1973; 2(2):163-72. PubMed ID: 4125448
    [No Abstract]   [Full Text] [Related]  

  • 7. Relative effectiveness of spinal cord and purified myelin basic protein in producing resistance to experimental allergic encephalomyelitis.
    McDermott JR; Keith AB
    Eur Neurol; 1979; 18(2):136-9. PubMed ID: 88369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Isolation and analysis of encephalitogenic fractions of spinal cord proteins].
    Zhitnukhin IuL; Pleskov VM
    Vopr Med Khim; 1978; 24(1):57-62. PubMed ID: 78578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myelin basic proteins of mammalian and submammalian vertebrates: encephalitogenic activities in guinea pigs and rats.
    Martenson RE; Deibler GE; Kies MW; Levine S; Alvord EC
    J Immunol; 1972 Aug; 109(2):262-70. PubMed ID: 4114825
    [No Abstract]   [Full Text] [Related]  

  • 10. Nasal administration of myelin basic protein prevents relapsing experimental autoimmune encephalomyelitis in DA rats by activating regulatory cells expressing IL-4 and TGF-beta mRNA.
    Bai XF; Shi FD; Xiao BG; Li HL; van der Meide PH; Link H
    J Neuroimmunol; 1997 Dec; 80(1-2):65-75. PubMed ID: 9413260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of resistance to experimental allergic encephalomyelitis in newborn guinea pigs.
    Staykova M; Kozovska M; Kirazjan N; Goranov I
    Neurol Psychiatr (Bucur); 1989; 27(3):225-9. PubMed ID: 2479972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response of rat encephalitogenic T cells to synthetic peptides of guinea pig myelin basic protein.
    Vandenbark AA; Hashim G; Offner H
    Ann N Y Acad Sci; 1988; 540():337-9. PubMed ID: 2462807
    [No Abstract]   [Full Text] [Related]  

  • 13. Correlation between strain differences in susceptibility to experimental allergic encephalomyelitis and the immune response to encephalitogenic protein in inbred guinea pigs.
    Webb C; Teitelbaum D; Arnon R; Sela M
    Immunol Commun; 1973; 2(2):185-92. PubMed ID: 4726657
    [No Abstract]   [Full Text] [Related]  

  • 14. Role of antibodies to galactocerebroside in experimental allergic encephalomyelitis.
    Hughes RA; Leibowitz S
    Immunology; 1975 Feb; 28(2):213-8. PubMed ID: 804435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of experimental allergic encephalomyelitis induced with spinal cord, basic protein, and synthetic encephalitogenic peptide.
    Hoffman PM; Gaston DD; Spitler LE
    Clin Immunol Immunopathol; 1973 Apr; 1(3):364-71. PubMed ID: 4127172
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunology cross-reactivity between spinal cord protein and myelin basic protein.
    Ramshaw IA; Welter D; MacPherson CF
    Int Arch Allergy Appl Immunol; 1982; 68(3):196-200. PubMed ID: 6177644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation and further characterization of the anti-encephalitogenic rat spinal cord protein from brain, spinal cord and peripheral nerves.
    MacPherson CF; Armstrong H; Yu SH
    Biochim Biophys Acta; 1981 Jul; 669(2):125-32. PubMed ID: 6169373
    [No Abstract]   [Full Text] [Related]  

  • 18. Allergic encephalomyelitis: cleavage of the C-tryptophyl bond in the encephalitogenic basic protein from bovne myelin.
    Eylar EH; Hashim GA
    Arch Biochem Biophys; 1969 Apr; 131(1):215-22. PubMed ID: 4305605
    [No Abstract]   [Full Text] [Related]  

  • 19. Autoimmunity to myelin basic protein.
    Swanborg RH; Holda JH; Killen JA
    Adv Exp Med Biol; 1982; 150():3-22. PubMed ID: 6183945
    [No Abstract]   [Full Text] [Related]  

  • 20. TCR peptide therapy decreases the frequency of encephalitogenic T cells in the periphery and the central nervous system.
    Vandenbark AA; Vainiene M; Celnik B; Hashim G; Offner H
    J Neuroimmunol; 1992 Aug; 39(3):251-60. PubMed ID: 1379608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.